Findex

Findex Debt/EBITDA

The Total Debt to EBITDA Ratio of Findex (3649.T) as of Nov 5, 2026 is 0.22. In the previous year, Total Debt to EBITDA Ratio was 0.06 — a change of 260.96% (higher).

Debt/EBITDA

0.22

YoY

260.96%

Last updated:

Total Debt to EBITDA Ratio of Findex is 2023 0.22 . Total Debt to EBITDA Ratio of Findex was 2022 0.06 . It decreases by 260.96% higher compared to the previous year.

The Findex Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2016
0.00 JPY
Jan 1, 2017
0.00 JPY
Jan 1, 2018
0.00 JPY
Jan 1, 2019
0.00 JPY
Jan 1, 2020
0.00 JPY
Jan 1, 2021
0.02 JPY
Jan 1, 2022
0.06 JPY
Jan 1, 2023
0.22 JPY
The Findex Debt/EBITDA history
YEARDebt/EBITDAYoY
0.22+260.96%
0.06+182.18%
0.02—
0.00—
0.00-100.00%
0.00-60.52%
0.00-7.12%
0.00-34.34%
0.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Findex Stock analysis

What does Findex do? FINDEX, Inc. generates revenue through its System Development segment, which offers medical system development, medical data integration and analysis, and office systems development. The Health Tech segment provides medical consulting, management consulting, healthcare data science, and AI services. Hospitals and clinics purchase the company's solutions for improving information management efficiency and enhancing medical practice quality. The System Development segment focuses on medical information systems, medical systems, and medical network systems that reduce administrative burdens for medical institutions. The company's products are tailored for hospitals and clinics, addressing their needs in medical information management and operational efficiency. The System Development segment emphasizes solutions that contribute to all patients by streamlining information management processes. The Health Tech segment leverages data science and AI to support healthcare consulting and management consulting services for medical institutions. FINDEX, Inc. serves medical institutions through two distinct business segments. The System Development segment develops systems that improve medical institution management and the quality of medical practice. The Health Tech segment integrates data science and AI into healthcare consulting and management consulting, targeting institutions seeking advanced data-driven solutions for operational improvements. Findex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Findex stock

Total Debt to EBITDA Ratio of Findex is 0.22 in 2023.

Total Debt to EBITDA Ratio of Findex changed from 0.06 to 0.22, representing a 260.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Findex since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Findex with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Findex

All Key Metrics — Findex